Octreotide: a potent new non-opiate analgesic for intrathecal infusion.


Somatostatin-14 has been reported to relieve severe cancer pain when given intraspinally. We have studied a stable analog, octreotide, which is suitable for long-term infusion by a drug pump. In preclinical trials in dogs, chronic intrathecal and intraventricular perfusion at 40 micrograms/h did not produce neurotoxicity. On the basis of these findings… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.